tiprankstipranks
Trending News
More News >
Balaxi Pharmaceuticals Limited (IN:BALAXI)
:BALAXI
India Market

Balaxi Pharmaceuticals Limited (BALAXI) Income Statement

Compare
0 Followers

Balaxi Pharmaceuticals Limited Income Statement

Last quarter (Q1 2026), Balaxi Pharmaceuticals Limited's total revenue was ₹707.42M, an increase of 7.80% from the same quarter last year. In Q1, Balaxi Pharmaceuticals Limited's net income was ₹2.90M. See Balaxi Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₹ 2.89B₹ 2.41B₹ 3.36B₹ 2.79B₹ 2.31B
Gross Profit
₹ 1.27B₹ 1.13B₹ 1.34B₹ 837.91M₹ 591.85M
Operating Expenses
₹ 904.62M₹ 656.74M₹ 792.32M₹ 334.80M₹ 167.68M
Depreciation and Amortization
₹ 18.95M₹ 20.98M₹ 17.52M₹ 5.12M₹ 2.98M
EBITDA
₹ 305.64M₹ 456.59M₹ 603.82M₹ 560.20M₹ 449.86M
Operating Income
₹ 363.99M₹ 467.31M₹ 586.30M₹ 503.11M₹ 424.17M
Other Income/Expenses
₹ -85.45M₹ -447.15M₹ -17.07M₹ 42.11M₹ 19.12M
Pretax Income
₹ 286.70M₹ 20.15M₹ 569.22M₹ 545.22M₹ 443.29M
Net Income
₹ 250.70M₹ -23.87M₹ 459.63M₹ 476.58M₹ 381.37M
Per Share Metrics
Basic EPS
₹ 4.53₹ -0.46₹ 9.16₹ 9.53₹ 7.63
Diluted EPS
₹ 4.53₹ -0.46₹ 9.08₹ 9.53₹ 7.63
Weighted Average Shares Outstanding
55.29M 52.67M 52.67M 52.67M 52.67M
Weighted Average Shares Outstanding (Diluted)
55.29M 52.67M 52.67M 52.67M 52.67M
Currency in INR

Balaxi Pharmaceuticals Limited Earnings and Revenue History